Fairvalue-Calculator Fairvalue-Calculator
EN DE

JW Pharmaceutical Corporation (001060) Fair Value & Analysis

Healthcare · KR · Market cap 625B KRW

Price25,000 KRW
Fair Value56,677 KRW
Upside+126.7%
Quality95/100
Evidence: High Range 35,595 KRW – 75,015 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

JW Pharmaceutical Corporation (001060) currently trades at 25,000 KRW, while our model-based Fair Value estimate is 56,677 KRW — implying the stock looks roughly 126.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% United Therapeutics Corporation (U2TH34) -73%

Frequently asked questions

Is JW Pharmaceutical Corporation (001060) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 56,677 KRW versus a price of 25,000 KRW — about +127% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 001060?
Our 21-model fair value for JW Pharmaceutical Corporation is 56,677 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 25,000 KRW.
What is the quality score of 001060?
JW Pharmaceutical Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.